Free Trial

Purple Biotech (PPBT) Competitors

Purple Biotech logo
$0.57 +0.00 (+0.09%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$0.58 +0.01 (+2.02%)
As of 09/12/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PPBT vs. NKGN, ALZN, CAPS, CDIO, VIVS, ACXP, PMCB, ENSC, SBFM, and PLRZ

Should you be buying Purple Biotech stock or one of its competitors? The main competitors of Purple Biotech include NKGen Biotech (NKGN), Alzamend Neuro (ALZN), Capstone Therapeutics (CAPS), Cardio Diagnostics (CDIO), VivoSim Labs (VIVS), Acurx Pharmaceuticals (ACXP), Nuvilex (PMCB), Ensysce Biosciences (ENSC), Sunshine Biopharma (SBFM), and Polyrizon (PLRZ). These companies are all part of the "pharmaceutical products" industry.

Purple Biotech vs. Its Competitors

NKGen Biotech (NYSE:NKGN) and Purple Biotech (NASDAQ:PPBT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Purple Biotech is trading at a lower price-to-earnings ratio than NKGen Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NKGen BiotechN/AN/A-$82.94M-$2.45-0.05
Purple BiotechN/AN/A-$7.24M-$0.42-1.36

NKGen Biotech's return on equity of 0.00% beat Purple Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
NKGen BiotechN/A N/A -479.36%
Purple Biotech N/A -14.00%-12.52%

Purple Biotech has a consensus price target of $33.00, suggesting a potential upside of 5,684.40%. Given Purple Biotech's stronger consensus rating and higher probable upside, analysts plainly believe Purple Biotech is more favorable than NKGen Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NKGen Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Purple Biotech
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

NKGen Biotech has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Purple Biotech has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

76.2% of NKGen Biotech shares are owned by institutional investors. Comparatively, 9.6% of Purple Biotech shares are owned by institutional investors. 10.4% of NKGen Biotech shares are owned by insiders. Comparatively, 3.0% of Purple Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Purple Biotech had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 4 mentions for Purple Biotech and 2 mentions for NKGen Biotech. Purple Biotech's average media sentiment score of 0.23 beat NKGen Biotech's score of 0.00 indicating that Purple Biotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NKGen Biotech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Purple Biotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Purple Biotech beats NKGen Biotech on 8 of the 13 factors compared between the two stocks.

Get Purple Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for PPBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PPBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PPBT vs. The Competition

MetricPurple BiotechMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.47M$3.20B$5.87B$10.14B
Dividend YieldN/A2.30%5.68%4.59%
P/E Ratio-1.3621.1774.5225.93
Price / SalesN/A480.02549.78198.13
Price / CashN/A46.6837.5660.44
Price / Book0.049.6112.166.29
Net Income-$7.24M-$53.29M$3.28B$270.77M
7 Day Performance-13.56%0.28%0.87%3.88%
1 Month Performance-74.42%5.73%4.96%4.88%
1 Year PerformanceN/A10.52%60.74%26.01%

Purple Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PPBT
Purple Biotech
2.6767 of 5 stars
$0.57
+0.1%
$33.00
+5,684.4%
N/A$1.47MN/A-1.3620Gap Up
NKGN
NKGen Biotech
0.1421 of 5 stars
$0.15
+5.3%
N/A-84.8%$6.74MN/A-0.03N/AGap Down
ALZN
Alzamend Neuro
3.5522 of 5 stars
$2.36
+1.7%
$45.00
+1,806.8%
-86.7%$6.72MN/A0.004Gap Down
CAPS
Capstone Therapeutics
N/A$1.16
-1.7%
N/AN/A$6.59M$44.88M0.0038
CDIO
Cardio Diagnostics
1.4622 of 5 stars
$3.63
-2.2%
N/A-56.6%$6.54M$40K0.001
VIVS
VivoSim Labs
0.678 of 5 stars
$2.49
-0.8%
N/AN/A$6.53M$140K-0.2420
ACXP
Acurx Pharmaceuticals
2.1595 of 5 stars
$4.13
+1.2%
$31.00
+650.6%
-89.3%$6.47MN/A-0.393Analyst Downgrade
PMCB
Nuvilex
1.5013 of 5 stars
$1.13
+20.1%
N/A-42.5%$6.40MN/A0.444Upcoming Earnings
Short Interest ↑
Gap Up
High Trading Volume
ENSC
Ensysce Biosciences
0.9131 of 5 stars
$2.10
-1.4%
N/A-55.3%$6.34M$5.21M-0.5210Positive News
SBFM
Sunshine Biopharma
2.914 of 5 stars
$1.41
+4.1%
$15.00
+963.8%
-46.4%$6.17M$34.87M-0.013
PLRZ
Polyrizon
N/A$1.00
-2.0%
N/AN/A$6.11MN/A0.00N/ANews Coverage

Related Companies and Tools


This page (NASDAQ:PPBT) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners